-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity launches pilot study with Brooke Army Medical Center for asthma, COPD tests

PUBT·04/28/2026 13:20:41
Listen to the news
bioAffinity launches pilot study with Brooke Army Medical Center for asthma, COPD tests
  • bioAffinity Technologies launched a pilot clinical study with Brooke Army Medical Center to evaluate sputum-based tests under development for asthma and COPD.
  • Results have not been presented; study will use automated analysis to identify inflammatory biomarkers intended to guide treatment selection and monitor therapy response.
  • Enrollment targets about 40 participants across asthma, COPD, and healthy control cohorts.
  • Program expands CyPath Lung platform beyond lung cancer into airway disease, targeting an asthma and COPD treatment market estimated at $92 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604280916BIZWIRE_USPR_____20260428_BW990130) on April 28, 2026, and is solely responsible for the information contained therein.